Pediatrics, Pediatric Endocrinology · Roseburg, OR
NPI
1144287848
Since 2006
Specialty
Pediatrics, Pediatric Endocrinology
Code 2080P0205X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2570 NW Edenbower Blvd Ste 100
Roseburg, OR, 97471
Phone (541) 677-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,007
90 services
Medicare patients, 2024
64
Average age 68
Drug cost, 2024
$1.5M
3,668 prescriptions
Company payments, 2025
$173
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Racine was code 83036 (blood count), 85 times for 62 patients. In total Michael Racine billed 90 services in 6 codes, and Medicare paid $1,007.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 85 | 62 | $9.52 | $809 |
By year: 2022 $758 for 87 services; 2023 $1,247 for 133 services; 2024 $1,007 for 90 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 85 | 62 | $9.52 | $809 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Racine prescribed most often to Medicare patients was Levothyroxine Sodium, with 278 prescriptions and refills. In total Michael Racine wrote 3,668 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 278 | 625 | 61 | $2,944 |
| Metformin Hcl Er Metformin Hcl | 269 | 439 | 60 | $2,549 |
| Trulicity Dulaglutide | 261 | 273 | 41 | $256K |
| Jardiance Empagliflozin | 253 | 356 | 41 | $203K |
| Ozempic Semaglutide | 229 | 254 | 40 | $227K |
| Semglee (Yfgn) Pen Insulin Glargine-Yfgn | 170 | 276 | 38 | $87K |
| Farxiga Dapagliflozin Propanediol | 89 | 161 | 25 | $82K |
| Metformin Hcl Generic | 70 | 176 | 20 | $607 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 56 | 91 | 13 | $42K |
| Novolog Flexpen Insulin Aspart | 56 | 78 | 13 | $9,706 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 55 | 116 | 18 | $8,558 |
| Lisinopril Generic | 52 | 104 | 12 | $316 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 52 | 80 | 13 | $25K |
| Testosterone Cypionate Generic | 51 | 68 | 12 | $1,966 |
| Humalog Kwikpen U-100 Insulin Lispro | 51 | 83 | 13 | $13K |
Brand drugs: 2,068 claims; generic drugs: 1,426 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Racine $173 ($173 in general payments such as food, travel and fees) from 5 companies. The largest payer was Tandem Diabetes Care, Inc. with $78.03.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.